These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 15935122)

  • 1. Behcet's Disease: Current Therapeutic Perspectives.
    Leiba M; Ehrenfeld M
    Curr Treat Options Cardiovasc Med; 2005 Jun; 7(2):139-148. PubMed ID: 15935122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interventions for the management of oral ulcers in Behçet's disease.
    Taylor J; Glenny AM; Walsh T; Brocklehurst P; Riley P; Gorodkin R; Pemberton MN
    Cochrane Database Syst Rev; 2014 Sep; 2014(9):CD011018. PubMed ID: 25254615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Behcet's disease therapy review].
    Vidaller Palacín A; Robert Olalla J; Sanuy Jiménez B; Rufi Rigau G; Folch Civit J; Charte González A
    An Med Interna; 2002 Nov; 19(11):594-8. PubMed ID: 12522899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Behçet's disease: a new target for anti-tumour necrosis factor treatment.
    Sfikakis PP
    Ann Rheum Dis; 2002 Nov; 61 Suppl 2(Suppl 2):ii51-3. PubMed ID: 12379622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Managing the symptoms of Behçet's disease.
    Evereklioglu C
    Expert Opin Pharmacother; 2004 Feb; 5(2):317-28. PubMed ID: 14996628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of Behçet's disease--an update.
    Kaklamani VG; Kaklamanis PG
    Semin Arthritis Rheum; 2001 Apr; 30(5):299-312. PubMed ID: 11303303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Update on the diagnosis and management of Behçet's disease.
    Rokutanda R; Kishimoto M; Okada M
    Open Access Rheumatol; 2015; 7():1-8. PubMed ID: 27790039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adamantiades-Behçet's disease therapy: current treatment options and recommendations with regard to the COVID-19 pandemic.
    Trevisini S; Trevisan G; Zalaudek I; Bonin S
    Dermatol Ther; 2022 Mar; 35(3):e15286. PubMed ID: 34962035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current and future treatments for Behçet's uveitis: road to remission.
    Mesquida M; Molins B; Llorenç V; Hernández MV; Espinosa G; Dick AD; Adán A
    Int Ophthalmol; 2014 Apr; 34(2):365-81. PubMed ID: 23729309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical manifestations and anti-TNF alpha therapy of juvenile Behçet's disease in Taiwan.
    Hu YC; Yang YH; Lin YT; Wang LC; Yu HH; Lee JH; Chiang BL
    BMC Pediatr; 2019 Jul; 19(1):232. PubMed ID: 31296171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitumor necrosis factor-alpha therapy for early postoperative recurrence of gastrointestinal Behçet's disease: report of a case.
    Byeon JS; Choi EK; Heo NY; Hong SC; Myung SJ; Yang SK; Kim JH; Song JK; Yoo B; Yu CS
    Dis Colon Rectum; 2007 May; 50(5):672-6. PubMed ID: 17216141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improvement of neurological and ocular symptoms of Behçet's disease after the introduction of infliximab.
    Barešić M; Reihl M; Habek M; Vukojević N; Anić B
    Rheumatol Int; 2018 Jul; 38(7):1301-1306. PubMed ID: 29777341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Acute psychosis and Behçet's disease: a case report].
    Nkam I; Cottereau MJ
    Encephale; 2006; 32(3 Pt 1):385-8. PubMed ID: 16840933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Efficacy of TNF-alpha antagonist and other immunomodulators in the treatment of patients with ophthalmologic manifestations of Behcet's disease and HLA B51 positive vasculitis].
    Zlatanović G; Jovanović S; Veselinović D; Zivković M
    Vojnosanit Pregl; 2012 Feb; 69(2):168-74. PubMed ID: 22500372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Behçet's disease--clinical presentation, diagnostic and therapeutic approach].
    Elbirt D; Asher I; Sthoeger ZM
    Harefuah; 2002 May; 141(5):462-7, 497. PubMed ID: 12073530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful treatment of life-threatening intestinal ulcer in Behçet's disease with infliximab: rapid healing of Behçet's ulcer with infliximab.
    Ju JH; Kwok SK; Seo SH; Yoon CH; Kim HY; Park SH
    Clin Rheumatol; 2007 Aug; 26(8):1383-5. PubMed ID: 17039261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of Behçet's disease.
    Bang D
    Yonsei Med J; 1997 Dec; 38(6):401-10. PubMed ID: 9509910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel approaches to Behçet's disease.
    Sakane T; Takeno M
    Expert Opin Investig Drugs; 2000 Sep; 9(9):1993-2005. PubMed ID: 11060788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thalidomide responsiveness in an infant with Behçet's syndrome.
    Shek LP; Lee YS; Lee BW; Lehman TJ
    Pediatrics; 1999 Jun; 103(6 Pt 1):1295-7. PubMed ID: 10353947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Behçet's disease. New perspectives on an enigmatic syndrome.
    Arbesfeld SJ; Kurban AK
    J Am Acad Dermatol; 1988 Nov; 19(5 Pt 1):767-79. PubMed ID: 3056991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.